Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINALS
Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease
Los niveles séricos de infliximab y adalimumab están asociados con remisión profunda en la enfermedad inflamatoria intestinal
Óscar Pascual-Marmaneu1,
Corresponding author
oscar_pas69@hotmail.com

Author of correspondence Óscar Pascual Marmaneu, Avda. Hermanos Bou, n.°13, 6° A, 12003 Castellón. Spain
, María D. Belles-Medall1, Raúl Ferrando-Piqueres1, Pedro Almela-Notari2, María Mendoza-Aguilera1, Tamara Álvarez-Martín1
1 Department of Pharmacy, Hospital General Universitario de Castellón, Castellón. Spain
2 Gastroenterology Department, Hospital General Universitario de Castellón. Castellón. Spain
Read
1058
Times
was read the article
350
Total PDF
708
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 12 4 16
2025 April 44 19 63
2025 March 58 24 82
2025 February 60 28 88
2025 January 58 30 88
2024 December 43 13 56
2024 November 56 31 87
2024 October 56 18 74
2024 September 53 24 77
2024 August 37 31 68
2024 July 43 20 63
2024 June 25 17 42
2024 May 43 24 67
2024 April 37 20 57
2024 March 18 4 22
2024 February 19 19 38
2024 January 13 9 22
2023 December 18 2 20
2023 November 15 13 28
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.